Viewing Study NCT00655395


Ignite Creation Date: 2025-12-24 @ 2:04 PM
Ignite Modification Date: 2026-02-21 @ 6:24 AM
Study NCT ID: NCT00655395
Status: TERMINATED
Last Update Posted: 2019-01-28
First Post: 2008-04-03
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Treatment of Elderly Patients With Acute Myeloid Leukemia (AML) and High Risk Myelodysplastic (MD) Syndrome With Laromustine and Infusional Cytarabine
Sponsor: Viron Therapeutics Inc
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Acute Myeloid Leukemia (AML) View
None Myelodysplastic Syndrome (MDS) View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Leukemia View
None MDS View